Monopar Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 54%
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics shares were halted due to a circuit breaker after a significant price increase, with the stock rising by 54%.
October 24, 2024 | 2:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Monopar Therapeutics experienced a significant stock price increase of 54%, leading to a trading halt due to a circuit breaker.
The 54% increase in Monopar Therapeutics' stock price indicates strong positive sentiment or news, leading to a circuit breaker halt. This suggests potential further upward movement or volatility in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100